Holen Sie sich die Stockscreener-App
26.28
1.82%
0.47
Vorhandelsmarkt:
26.08
-0.20
-0.76%
Viking Therapeutics Inc Aktie (VKTX) Neueste Nachrichten
Applying Elliott Wave Theory to Viking Therapeutics Inc.July 2025 Review & AI Enhanced Trade Execution Alerts - newser.com
Will Viking Therapeutics Inc. stock attract more institutional investors2025 Top Decliners & Technical Buy Zone Confirmations - newser.com
BTIG Reiterates a Buy Rating on Viking Therapeutics (VKTX) With a $125 PT - Yahoo Finance
BTIG Reiterates a Buy Rating on Viking Therapeutics (VKTX) - MSN
Why This Beaten-Down GLP-1 Stock Could Be a Steal - AOL.com
Why This Beaten-Down GLP-1 Stock Could Be a Steal - The Motley Fool
What to expect from Viking Therapeutics Inc. in the next 30 daysQuarterly Portfolio Summary & Long-Term Safe Investment Plans - newser.com
HC Wainwright & Co. Reiterates Viking Therapeutics (VKTX) Buy Recommendation - Nasdaq
H.C. Wainwright Maintains Viking Therapeutics(VKTX.US) With Buy Rating, Maintains Target Price $102 - 富途牛牛
Viking Therapeutics: Promising Position in GLP-1 Market with Strategic Growth Potential - TipRanks
VKTX: HC Wainwright Reiterates Buy Rating and Maintains Price Ta - GuruFocus
Viking Therapeutics' (VKTX) "Buy" Rating Reaffirmed at HC Wainwright - MarketBeat
Is Viking Therapeutics Inc. reversing from oversold territoryWeekly Investment Report & Safe Capital Growth Tips - newser.com
Will Viking Therapeutics Inc. stock maintain momentum in 2025Watch List & Verified Momentum Stock Alerts - newser.com
Is Viking Therapeutics Inc. stock oversold or undervaluedJuly 2025 Catalysts & Free High Accuracy Swing Entry Alerts - newser.com
Short interest data insights for Viking Therapeutics Inc.Trade Entry Summary & Stepwise Trade Execution Plans - newser.com
Comparing Viking Therapeutics Inc. in custom built stock radarsWall Street Watch & Weekly Top Gainers Trade List - newser.com
Viking Therapeutics: Overdue For Gains (NASDAQ:VKTX) - Seeking Alpha
What drives Viking Therapeutics Inc 1VT stock priceResistance Breakout Alerts & Small Investment Capital Gains - earlytimes.in
Is Viking Therapeutics Inc a good long term investmentTechnical Analysis Insights & Low Risk Wealth Plans - Early Times
Using flow based indicators on Viking Therapeutics Inc.July 2025 Outlook & Weekly Return Optimization Alerts - newser.com
Analyzing Viking Therapeutics Inc. with risk reward ratio chartsVolume Spike & Weekly Watchlist for Hot Stocks - newser.com
Novo Nordisk vs. Viking Therapeutics: Which GLP-1 Stock is a Safer Bet? - MSN
Pfizer Is Buying Weight Loss Biotech Metsera. Here's Why Viking Therapeutics Shareholders May Be Cheering. - MSN
Viking Therapeutics: A Huge Reward Or A Total Loss (NASDAQ:VKTX) - Seeking Alpha
Pfizer Acquires Metsera, Viking Therapeutics’ Prospects Attract Attention - NAI500
Viking Therapeutics, Inc. (VKTX) Declines More Than Market: Some Information for Investors - sharewise.com
Viking Therapeutics (NASDAQ:VKTX) Shares Down 5.8%Here's Why - MarketBeat
Can Viking Therapeutics Hold Its Edge as Obesity Rivalry Heats Up? - sharewise.com
Brokers Suggest Investing in Viking Therapeutics (VKTX): Read This Before Placing a Bet - sharewise.com
Viking Therapeutics Stock Surges on Promising Obesity Drug Pipeline - AD HOC NEWS
Viking Therapeutics (NASDAQ:VKTX) Trading 6.6% HigherTime to Buy? - MarketBeat
Viking Therapeutics (NASDAQ:VKTX) Trading 7.4% HigherWhat's Next? - MarketBeat
Viking Therapeutics : September 2025 Corporate Presentation - MarketScreener
Are Safety Concerns Around VK2735 Shaping Investor Perceptions of Viking Therapeutics (VKTX)? - simplywall.st
Why Viking Therapeutics Stock Crashed Today - aol.com
U.S. Capital Wealth Advisors LLC Purchases 27,795 Shares of Viking Therapeutics, Inc. $VKTX - MarketBeat
Viking Therapeutics Shares Dip as Pfizer Chooses Rival Acquisition - AD HOC NEWS
Viking Therapeutics, Inc. (VKTX) Falls More Steeply Than Broader Market: What Investors Need to Know - sharewise.com
Pfizer’s $5B Bet on Metsera ($MTSR) vs Viking Therapeutics ($VKTX) - MSN
Strs Ohio Invests $604,000 in Viking Therapeutics, Inc. $VKTX - MarketBeat
Viking Therapeutics at Bernstein Forum: Strategic Moves in Obesity Market - Investing.com
Transcript : Viking Therapeutics, Inc. Presents at Bernstein 2nd Annual Global Healthcare Conference, Sep-23-2025 11 - MarketScreener
Viking Therapeutics at Bernstein Forum: Strategic Moves in Obesity Market By Investing.com - Investing.com UK
Viking Therapeutics Stock Gets Boost From Pfizer-Metsera Deal, Says BTIG — Retail Slams Rivals For Buying ‘Inferior Pipelines’ - Stocktwits
Exchange Traded Concepts LLC Buys 20,296 Shares of Viking Therapeutics, Inc. $VKTX - MarketBeat
Viking Therapeutics: Oral Study Disappoints, Competitor Gets Bought Out (Rating Downgrade) - Seeking Alpha
Why Viking Therapeutics Shares Are Climbing High - TipRanks
BTIG Reiterates Buy Rating for Viking Therapeutics (VKTX) with $125 Target | VKTX Stock News - GuruFocus
BTIG Maintains Viking Therapeutics(VKTX.US) With Buy Rating, Maintains Target Price $125 - 富途牛牛
Viking Therapeutics (NASDAQ:VKTX) Earns Buy Rating from BTIG Research - MarketBeat
Viking Therapeutics: Strong Buy Rating Amid Strategic Positioning and Acquisition Potential in the Metabolic Disease Market - TipRanks
Viking Therapeutics (VKTX): Revisiting Valuation After Safety Concerns From Oral Obesity Drug Trial News - simplywall.st
Kingstone Capital Partners Texas LLC Invests $1.37 Million in Viking Therapeutics, Inc. $VKTX - MarketBeat
2.36%
1.10%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):